Ear, Nose, and Throat Devices Market Share & Growth [2031]
Ear, Nose, and Throat Devices Market Share & Growth [2031]
Segments - Ear, Nose, and Throat (ENT) Devices Market by Type (Diagnostic Devices [Hearing Screening Devices and Endoscopes], Surgical Devices [Ear Tubes, Powdered Surgical Instruments, and ENT Supplies], Hearing Aids, and Others), End-user (ENT Clinics, Hospitals & Ambulatory Settings, and Home Use), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5467
| 4.3 Rating
| 80 Reviews
| 198 Pages
| Format :
Report Description
The global ear, nose, and throat (ENT) devices market size was USD 24 Bn in 2022 and is likely to reach USD 36 Bn by 2031, expanding at a CAGR of 5.75% during 2023–2031. The market growth is attributed to the rising prevalence of ENT-related disorders coupled with the increasing use of technological advancements in medical devices.
Growing adoption of advanced technology solutions such as artificial intelligence (AI) and machine learning (ML) in ENT devices are likely to boost the market. These technologies improve treatment planning, diagnostic accuracy, and patient management. ENT medical devices are also used for the automatic identification of auditory brainstem response.
- For instance, in October 2021, Audibel launched the “Arc AI” Hearing Aid line, a full line of AI-driven hearing aids that support the most advanced sound quality available. AI and industry-leading technology are enabling advancements in hearing devices that not only support hearing effortlessly but also help to live actively.
Ear, Nose, and Throat (ENT) devices are medical devices used to diagnose, treat, and manage disorders and conditions related to otolaryngology/ENT. ENT surgery procedures are performed to fix injuries or defects that cause problems such as pain, frequent infections, and breathing complications in the ear, nose, and throat region. Some common ENT disorders that may require ENT surgery include serious injuries to the ear, nose, throat, and other head & neck problems.
Worldwide, numerous individuals have severe otolaryngology problems such as breathing & sleeping issues, head & neck cancer, allergies, hearing & balance, skin disorders, and even facial injuries. In serious cases, these disorders require to be attended to by ENT specialists.
The market report finds that the COVID-19 pandemic hampered the ear, nose, and throat devices market, due to the closures of ENT clinics and termination of elective surgical procedures in hospitals. As COVID-19 spread rapidly, individuals around the world postponed non-essential visits to clinics, which slowed the market growth. However, with the large-scale vaccinations and decreasing COVID-19 cases, demand for ENT devices and treatment is back on the recovery track, which is expected to regain the market in the coming years.
Ear, Nose, and Throat (ENT) Devices Market Dynamics
Major Drivers
Increasing prevalence of ENT disorders is a key driver of the market as these are some of the most common healthcare complications occurring among the worldwide populations. This, in turn, is driving the need to consult an otolaryngologist.
With the rising awareness about ENT disorders, individuals are actively seeking consultation and treatment from otolaryngologists. If an individual develops certain symptoms such as severe allergies, hearing loss, snoring, sleep apnea, cough, vertigo, and others, primary care physicians refer to an otolaryngologist.
- According to the Cleveland Clinic, in the U.S., around 27 million people visit otolaryngologists each year.
Increasing surgical procedures for ENT due to supportive reimbursement policies is expected to drive the market. ENT care is reimbursed in most cases in developed countries. ENT surgical procedures covered under reimbursement policies in most countries are computer-assisted surgical navigation, balloon sinus dilation, tongue suspension, endoscopic sinus surgery, and inferior turbinoplasty procedures, which require the use of advanced ENT devices.
The concern about treatment costs is minimal owing to such compensation. However, ENT surgeries performed primarily for snoring, otoplasty, pillar procedure, laser ear surgery, cosmetic rhinoplasty, injection snoreplasty, and radiofrequency ablation devices are not covered in reimbursement policies.
Existing Restraints
Shortage of otolaryngology services and surgeons in developing regions, due to a lack of resources is expected to hamper the ear, nose, and throat devices market. Around 80% of the world’s population resides in developing nations and ENT resources are often limited & in some cases non-existent.
-
According to the survey published by the National Institutes of Health, there is a severe shortage of ENT surgeons and a scarcity of ENT training programs in 18 countries within the African continent. The number of ENT surgeons per 10,000 population in these countries was five times lower than in the UK.
-
According to the World Health Organization (WHO), there are around 72 million hearing aids users internationally and estimated that 20% of hearing loss sufferers can benefit from the increased availability of hearing aids in developing countries.
Emerging Opportunities
High demand for cosmetic ENT treatments and increasing product development & launch activities are likely to create opportunities for the market players. The key players in the ENT devices market are developing and launching new products that improve comfort and convenience. In addition, the demand for cosmetic procedures and treatments is expanding with the innovation of minimally invasive surgery devices.
Several ENT treatments and devices are used for cosmetics such as color science. Color Science is a skincare and cosmetic line. Treatments offered include anti-aging serum, pigment perfector, sun protection, and redness corrector. For cosmetics, Color Science offers a series of foundations, mascara, primers, bronzers, and more.
Scope of Ear, Nose, and Throat (ENT) Devices Market Report
The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Ear, Nose, and Throat (ENT) Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Type (Diagnostic Devices [Hearing Screening Devices and Endoscopes], Surgical Devices [Ear Tubes, Powdered Surgical Instruments, ENT Supplies], Hearing Aids, and Others) and End-user (ENT Clinics, Hospitals & Ambulatory Settings, and Home Use), |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Starkey Laboratories, Inc; Sonova; Rion Co Ltd; Richard Wolf GmbH; PENTAX Medical; Olympus Corporation; Meril Life Sciences Pvt. Ltd.; Medical Device Business Services, Inc.; GN Store Nord A/S; Demant A/S; Audina Hearing Instruments, Inc.; and Ambu Inc. |
Ear, Nose, and Throat (ENT) Devices Market Segment Insights
Type Segment Analysis
Based on type, the ear, nose, and throat (ENT) devices market is divided into diagnostic devices, surgical devices, hearing aids, and others. The diagnostics devices segment is further classified as hearing screening devices and endoscopes. The surgical devices segment is again divided into ear tubes, powdered surgical instruments, and ENT supplies.
The surgical devices segment is expected to expand at a significant pace during the projection period, due to the increasing demand for minimally invasive surgeries and the rising prevalence of ENT disorders. ENT surgeons use several specialized instruments during surgical procedures, including suction devices, ontological drill burs, microscopes, drills, lasers, and nasal packing devices.
The hearing aids segment is anticipated to hold a key market share in the coming years, due to the increasing adoption of hearing implants and increasing awareness about cochlear implants as non-invasive procedures. Several key players in the ENT devices space are focusing on launching new products that improve comfort and convenience.
- In August 2021, Cochlear Limited, a global leader in implantable hearing solutions, launched Nucleus Kanso 2 Sound Processor in Singapore. This new launch reflects Cochlear’s ongoing commitment to innovation in hearing technology, which provides amplified access to smartphone connectivity and helps to improve hearing performance in people with hearing loss.
End-user Segment Analysis
On the basis of end-user, the market is segregated into ENT clinics, hospitals & ambulatory settings, and home use. The hospitals & ambulatory settings segment is projected to register a considerable CAGR during the forecast period, due to the increasing disposable income and rising affordability of ENT treatment.
The segment growth is further attributed to the increasing prevalence of hearing loss and the rapidly growing elderly population. Due to rising awareness about ENT disorders and their treatment options, individuals with such complications are actively seeking consultation and treatment from hospitals.
Regional Analysis
In terms of region, the global ear, nose, and throat (ENT) devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the high prevalence of ENT-related disorders and increasing demand for hearing care products in the region.
- According to the report published on March 25, 2021, National Institute of Health (NIH), around 2 to 3 out of 1,000 children in the United States are born with a detectable level of hearing loss in one or both ears. More than 90% of deaf children are born to hearing parents. Approximately 15% of American adults aged 18 years (about 37.5 million) have reported some trouble with hearing.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to the increasing prevalence of ENT-related disorders and increasing investments in the development of better healthcare infrastructure. The market growth in the region is further attributed to the expansion of healthcare facilities and growing awareness about early diagnosis. Supportive policies by regulatory bodies for the advancement of ENT devices are expected to boost the market in the region.
Segments
The global ear, nose, and throat (ENT) devices market has been segmented on the basis of
Type
- Diagnostic Devices
- Hearing Screening Devices
- Endoscopes
- Surgical Devices
- Ear Tubes
- Powdered Surgical Instruments
- ENT Supplies
- Hearing Aids
- Others
End User
- ENT Clinics
- Hospitals & Ambulatory Settings
- Home Use
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Starkey Laboratories, Inc
- Sonova
- Rion Co Ltd
- Richard Wolf GmbH
- PENTAX Medical
- Olympus Corporation
- Meril Life Sciences Pvt. Ltd.
- Medical Device Business Services, Inc.
- GN Store Nord A/S
- Demant A/S
- Audina Hearing Instruments, Inc.
- Ambu Inc.
Competitive Landscape
Key players competing in the global ear, nose, and throat (ENT) devices market are Starkey Laboratories, Inc; Sonova; Rion Co Ltd; Richard Wolf GmbH; PENTAX Medical; Olympus Corporation; Meril Life Sciences Pvt. Ltd.; Medical Device Business Services, Inc.; GN Store Nord A/S; Demant A/S; Audina Hearing Instruments, Inc.; and Ambu Inc.
These key players adopt various strategies including mergers, acquisitions, collaboration, partnerships, product launches, and production expansion to expand their consumer base globally.
-
In January 2023, Sonova launched Sennheiser conservation clear plus earbuds, a speech enhanced hearable, which helps individuals to expand their comprehension in noisy environments. It is a significant milestone for Sonova’s business for establishing a new category of hearing solutions for consumers.
-
In September 2021, Acclarent, Inc., a part of Johnson & Johnson Medical Devices company, launched its first-ever ENT navigation technology powered by Artificial Intelligence (AI). This new software contains TruSeg and TruPath for use with the TruDi navigation system and leverages a machine-learning (ML) algorithm.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Ear, Nose, and Throat Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ear, Nose, and Throat Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ear, Nose, and Throat Devices Market - Supply Chain
4.5. Global Ear, Nose, and Throat Devices Market Forecast
4.5.1. Ear, Nose, and Throat Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ear, Nose, and Throat Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Ear, Nose, and Throat Devices Market Absolute $ Opportunity
5. Global Ear, Nose, and Throat Devices Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Ear, Nose, and Throat Devices Market Size and Volume Forecast by Types
5.3.1. Diagnostic Devices
5.3.2. Surgical Devices
5.3.3. Hearing Aids
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Ear, Nose, and Throat Devices Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Ear, Nose, and Throat Devices Market Size and Volume Forecast by End Users
6.3.1. ENT Clinics
6.3.2. Hospitals & Ambulatory Settings
6.3.3. Home Use
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Ear, Nose, and Throat Devices Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Ear, Nose, and Throat Devices Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Ear, Nose, and Throat Devices Demand Share Forecast, 2019-2026
8. North America Ear, Nose, and Throat Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Ear, Nose, and Throat Devices Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Ear, Nose, and Throat Devices Market Size and Volume Forecast by Types
8.4.1. Diagnostic Devices
8.4.2. Surgical Devices
8.4.3. Hearing Aids
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Ear, Nose, and Throat Devices Market Size and Volume Forecast by End Users
8.7.1. ENT Clinics
8.7.2. Hospitals & Ambulatory Settings
8.7.3. Home Use
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Ear, Nose, and Throat Devices Demand Share Forecast, 2019-2026
9. Latin America Ear, Nose, and Throat Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Ear, Nose, and Throat Devices Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Ear, Nose, and Throat Devices Market Size and Volume Forecast by Types
9.4.1. Diagnostic Devices
9.4.2. Surgical Devices
9.4.3. Hearing Aids
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Ear, Nose, and Throat Devices Market Size and Volume Forecast by End Users
9.7.1. ENT Clinics
9.7.2. Hospitals & Ambulatory Settings
9.7.3. Home Use
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Ear, Nose, and Throat Devices Demand Share Forecast, 2019-2026
10. Europe Ear, Nose, and Throat Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Ear, Nose, and Throat Devices Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Ear, Nose, and Throat Devices Market Size and Volume Forecast by Types
10.4.1. Diagnostic Devices
10.4.2. Surgical Devices
10.4.3. Hearing Aids
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Ear, Nose, and Throat Devices Market Size and Volume Forecast by End Users
10.7.1. ENT Clinics
10.7.2. Hospitals & Ambulatory Settings
10.7.3. Home Use
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Ear, Nose, and Throat Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Ear, Nose, and Throat Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Ear, Nose, and Throat Devices Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Ear, Nose, and Throat Devices Market Size and Volume Forecast by Types
11.4.1. Diagnostic Devices
11.4.2. Surgical Devices
11.4.3. Hearing Aids
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Ear, Nose, and Throat Devices Market Size and Volume Forecast by End Users
11.7.1. ENT Clinics
11.7.2. Hospitals & Ambulatory Settings
11.7.3. Home Use
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Ear, Nose, and Throat Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Ear, Nose, and Throat Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Ear, Nose, and Throat Devices Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Ear, Nose, and Throat Devices Market Size and Volume Forecast by Types
12.4.1. Diagnostic Devices
12.4.2. Surgical Devices
12.4.3. Hearing Aids
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Ear, Nose, and Throat Devices Market Size and Volume Forecast by End Users
12.7.1. ENT Clinics
12.7.2. Hospitals & Ambulatory Settings
12.7.3. Home Use
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Ear, Nose, and Throat Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Ear, Nose, and Throat Devices Market: Market Share Analysis
13.2. Ear, Nose, and Throat Devices Distributors and Customers
13.3. Ear, Nose, and Throat Devices Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Starkey Laboratories, Inc
13.4.2. Sonova
13.4.3. Rion Co Ltd
13.4.4. Richard Wolf GmbH
13.4.5. PENTAX Medical
13.4.6. Olympus Corporation
13.4.7. Meril Life Sciences Pvt. Ltd.
13.4.8. Medical Device Business Services, Inc.
13.4.9. GN Store Nord A/S
13.4.10. Demant A/S
13.4.11. Audina Hearing Instruments, Inc.
13.4.12. Ambu Inc.
Methodology
Related Reports
Some other reports from this category!
Our Clients
